Charlie McLeod
-
- Antibiotic Use and Resistance 3
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Cystic Fibrosis Research Advances 7
- Neonatal Respiratory Health Research 3
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Economic and Environmental Valuation 3
-
- Patient Satisfaction in Healthcare 2
-
- Delphi Technique in Research 2
- Co-authors
- Tom SnellingSteve WebbRichard NormanRob BairdEdward LittonBenjamin R. SavillePeter S MorrisPaul Bauert
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Charlie McLeod
25 papers receiving 317 citations
Peers
Comparison fields: 5 of 109
- Applied Microbiology and Biotechnology 16
- Epidemiology 140
- Infectious Diseases 51
- Emergency Medical Services 13
- Statistics and Probability 14
Countries citing papers authored by Charlie McLeod
This map shows the geographic impact of Charlie McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie McLeod more than expected).
Fields of papers citing papers by Charlie McLeod
This network shows the impact of papers produced by Charlie McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie McLeod. The network helps show where Charlie McLeod may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charlie McLeod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 13 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 88 | |
| 18 | 2018 | 15 | |
| 19 | 2015 | 26 | |
| 20 | 2014 | 73 |
About Charlie McLeod
Charlie McLeod is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Parasitology, having authored 30 papers that have together received 324 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Economic and Environmental Valuation (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Antibiotic Use and Resistance (3 papers), Neonatal Respiratory Health Research (3 papers), Patient Satisfaction in Healthcare (2 papers) and Delphi Technique in Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (16 citations), Epidemiology (140 citations) and Infectious Diseases (51 citations). Charlie McLeod has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Tom Snelling, Steve Webb, Richard Norman, Rob Baird, Edward Litton, Benjamin R. Saville, Peter S Morris, Paul Bauert, Linda Ward and B. J. Currie. Their work appears in journals such as Clinical Infectious Diseases, Frontiers in Immunology and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.